20/20 Biolabs, Inc. — Form 8-K
Filed August 19, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Form 8-K filed 2026-08-19 reports Item 5.07 (Submission of Matters to a Vote of Security Holders) for period ending 2026-08-18. No specific vote details, counterparties, dollar amounts, percentages, or share counts are disclosed in the available filing text. The document contains only structural metadata and does not substantively describe what was voted on or the outcomes.
Why this rating
Routine disclosure of stockholder vote submission; no material details provided; standard periodic SEC compliance filing.
Extracted items
See more from August 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.